PharmaSUG2015paper·US·Statistics and PharmacokineticsGrowing Needs in Drug Industry for NONMEM Programmers Using SAS® SP07See metadata
PharmaSUG2015paper·US·Statistics and PharmacokineticsHow To Use Latent Analyses Within Survey Data Can Be Valuable Additions to Any Regression Model SP08See metadata
PharmaSUG2015paper·US·Statistics and Pharmacokinetics%PIC_NPMLE: A SAS Macro For Nonparametric Estimation In Partly Interval-Censored Survival Data SP10See metadata
PharmaSUG2015paper·China·Statistics including PharmacokineticsHands-on Tutorial for Piecewise Linear Mixed-effects Models Using SAS® PROC MIXED 08 ShanghaiSee metadata
PharmaSUG2015paper·China·Statistics including PharmacokineticsWhy Statistical Analysis Plan (SAP) should be comprehensive. 11 ShanghaiSee metadata
PharmaSUG2015paper·China·Statistics including PharmacokineticsComparison of Three Methods in Calculating Confidence Intervals for Rate Differences in Non-inferior Clinical Trials 35 ShanghaiSee metadata
PharmaSUG2015paper·China·Statistics including PharmacokineticsSurvival Plots using SAS PROC LIFETEST, GPLOT, and SGPLOT: What are their difference? 56 ShanghaiSee metadata
PharmaSUG2015paper·China·Statistics including PharmacokineticsThe Application of Tolerance Interval in Defining Drug Response for Biomarker 57 ShanghaiSee metadata
PharmaSUG2015paper·China·Statistics including PharmacokineticsUse of SAS® for Risk-Based Monitoring of Survival Endpoints and Adverse Event Data in Clinical Trials 58 ShanghaiSee metadata
PharmaSUG2015paper·China·Statistics including PharmacokineticsClinical trials optimization: Monte Carlo Simulation modeling and SAS applications 61 ShanghaiSee metadata
PharmaSUG2015paper·US·Submission StandardsGetting Loopy with SAS® DICTIONARY Tables: Using Metadata from DICTIONARY Tables to Fulfill Submission Requirements SS01See metadata
PharmaSUG2015paper·US·Submission StandardsJapanese submission/approval processes from programming perspective SS02See metadata
PharmaSUG2015paper·US·Submission StandardsBegin with the End in Mind – Using FDA Guidance Documents as Guideposts when Planning, Delivering and Archiving Clinical Trials SS04See metadata
PharmaSUG2015paper·US·Submission StandardsOSI Packages: What you need to know for your next NDA or BLA Submission SS05See metadata
PharmaSUG2015paper·US·Submission StandardsGetting Rid of Bloated Data in FDA Submissions SS08-SASSee metadata
PharmaSUG2015paper·US·Submission StandardsSAS® Tools for Working with Dataset-XML files SS09-SASSee metadata
PharmaSUG2015paper·US·Submission StandardsUsing SAS® Clinical Data Integration to Roundtrip a Complete Study Study Metadata (Define-XML) and Study Data (Dataset-XML) SS10-SASSee metadata
PharmaSUG2015paper·US·Techniques and TutorialsTeam-work and Forensic Programming: Essential Foundations of Indestructible Projects TT01See metadata
PharmaSUG2015paper·US·Techniques and TutorialsPhantom of the ODS – How to run cascading compute blocks off of common variables in the data set for complex tasks. TT02See metadata